# Yuki Gosei Kogyo Co., Ltd. – FDA Inspection, Nov 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/yuki-gosei-kogyo-co-ltd/4591bd15-7e1f-4495-be9d-1aa9f46950b1
Source feed: FDA_Inspections

> FDA inspection 1037750 of Yuki Gosei Kogyo Co., Ltd., November 17, 2017. Classification: Official Action Indicated (OAI). Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1037750
- Company Name: Yuki Gosei Kogyo Co., Ltd.
- Inspection Date: 2017-11-17
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1308030 - 2026-02-06](https://www.keypedia.com/records/fda_inspections/yuki-gosei-kogyo-co-ltd/c18dd426-6a61-482a-8f20-dbd250cff495)
- FDA Inspection 1149608 - 2021-07-28
- FDA Inspection 988050 - 2016-09-02
- FDA Inspection 875345 - 2014-03-07
- FDA Inspection 791202 - 2012-06-22

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/yuki-gosei-kogyo-co-ltd/94411f09-2744-47ca-9250-20774e61824e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
